Park Aerospace (PKE) director sells 3,000 shares at $19.44

Park Aerospace (PKE) reported insider activity by a director on Form 4.

Rhea-AI Filing Summary

Park Aerospace (PKE) reported insider activity by a director on Form 4. The filing shows an option exercise of 3,000 shares at $5.23 on 11/04/2025, followed by an open‑market sale of 3,000 shares at $19.44 on 11/06/2025. After these transactions, the director held 1,000 common shares directly.

The exercised option was originally granted on 01/12/2017 and expires on 01/12/2026. The filing also lists additional director stock options outstanding with grant dates from 05/07/2020 through 06/16/2026, each covering 3,500 underlying shares with stated exercise prices and expirations.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 10 txns

Insider Smith Carl William

Role Director

Sold 3,000 shs ($58K)

Approx. gross sale proceeds $58K

Approx. exercise cost $16K

Type	Security	Shares	Price	Value
Sale	Common Stock	3,000	$19.44	$58K
Exercise	Right to buy option	3,000	$0.00	$0.00
Exercise	Common Stock	3,000	$5.23	$16K
holding	Right to buy option	--	--	--
holding	Right to buy option	--	--	--
holding	Right to buy option	--	--	--
holding	Right to buy option	--	--	--
holding	Right to buy option	--	--	--
holding	Right to buy option	--	--	--
holding	Right to buy option	--	--	--

Holdings After Transaction: Right to buy option — 24,500 contracts (Direct); Common Stock — 1,000 shares (Direct)

Footnotes (1)

1. F1. Option is exercisable, commencing on the date indicated, as to 25% of the aggregate number of shares listed and as to an additional 25% of such shares on each of the succeeding three anniversaries of such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Park Aerospace (PKE) disclose?

A director exercised 3,000 options at $5.23 on 11/04/2025 and sold 3,000 shares at $19.44 on 11/06/2025.

How many Park Aerospace shares did the director own after the transactions?

The director owned 1,000 common shares directly after the reported transactions.

What were the prices involved in the Park Aerospace Form 4?

Option exercise price was $5.23; sale price was $19.44 per share.

What is the origin and expiration of the exercised option?

The option was granted on 01/12/2017 and expires on 01/12/2026.

Does the filing list additional options for the director?

Yes. It lists several outstanding director options, each for 3,500 underlying shares with grant dates from 05/07/2020 to 06/16/2026 and corresponding expirations.

What is the director’s relationship to Park Aerospace?

The reporting person is a Director of Park Aerospace Corp.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/06/2025 - 02:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Carl William

(Last) (First) (Middle)

9830 E. EMERALD DR.

(Street)

SUN LAKE AZ 85248

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PARK AEROSPACE CORP [ PKE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2025		M		3,000	A	$5.23	4,000	D
Common Stock	11/06/2025		S		3,000	D	$19.44	1,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Right to buy option(1)	$5.23	11/04/2025		M			3,000	01/12/2017	01/12/2026	Common Stock	3,000	$0	0	D
Right to buy option(1)	$14.44							05/07/2020	05/07/2029	Common Stock	3,500		3,500	D
Right to buy option(1)	$11.58							04/09/2021	04/09/2030	Common Stock	3,500		3,500	D
Right to buy option(1)	$12.8							04/02/2022	04/02/2031	Common Stock	3,500		3,500	D
Right to buy option(1)	$11.06							04/12/2023	04/12/2032	Common Stock	3,500		3,500	D
Right to buy option(1)	$13.08							05/01/2024	05/01/2033	Common Stock	3,500		3,500	D
Right to buy option(1)	$13.26							06/18/2025	06/18/2034	Common Stock	3,500		3,500	D
Right to buy option(1)	$14							06/16/2026	06/16/2035	Common Stock	3,500		3,500	D

Explanation of Responses:

1. Option is exercisable, commencing on the date indicated, as to 25% of the aggregate number of shares listed and as to an additional 25% of such shares on each of the succeeding three anniversaries of such date.

	/s/ Constantine Petropoulos, by Power of Attorney	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.